Stocks and Shares
The latest news, updates and opinions on Stocks and Shares from the expert team here at MoneyWeek
Explore Stocks and Shares
Latest
-
Share tips of the week – 16 September
Tips MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
By moneyweek Published
-
-
A cheap and cheerful pub chain to buy now
Tips JD Wetherspoon’s shares have slumped this year. Yet a recovery is now in sight, says David J Stevenson.
By David J Stevenson Published
-
Three Japanese stocks to buy now
Tips Professional investor Joe Bauernfreund of the AVI Japan Opportunity Trust highlights three of his favourite Japanese stocks to buy now.
By Joe Bauernfreund Published
-
These three companies are trying to change the world
Tips Professional investor Ben Ritchie of the Dunedin Income Growth Investment Trust picks three responsible stocks to buy now that are working to solve global problems.
By Ben Ritchie Published
-
Share tips of the week – 9 September
Tips MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
By moneyweek Published
-
Buy stocks with wide moats to protect your profits
Tips Companies with wide "moats" – attributes that give them an enduring competitive advantage – tend to thrive over the long term. Dr Mike Tubbs explains how to identify them and how to invest in them.
By Dr Mike Tubbs Published
-
COMPASS Pathways: the biotech aiming to beat depression with magic mushrooms
Tips Biotech company COMPASS Pathways has produced a drug to treat depression based on the psychedelic substance found in magic mushrooms. Bruce Packard assesses the stock's potential for investors.
By Bruce Packard Published
-
5 defence stocks to arm your portfolio
Tips Defence stocks have been in the spotlight for more than a year owing to geopolitical trends predating the Ukraine war and low valuations. Alec Cutler, portfolio manager of the Orbis Global Balanced and Cautious Funds, presents the bullish case.
By Alec Cutler Published
-
Why this biotech company has years of growth ahead
Analysis Zimmer Biomet, a leader in the worldwide market for hip and knee joints, enjoys a competitive advantage and has years of growth ahead, says Dr Mike Tubbs.
By Dr Mike Tubbs Published